Gene: CDKN2A

Direct link to NCBI to retrieve information for Gene: CDKN2A

Study	Ethnicity	Population	Source	Number of Melanoma Cases	Number of Controls	Polymorphism	Major Allele	Minor Allele	Association with Melanoma
Hoiom, Pigment Cell Melanoma Res, 2009	Caucasian	Sweden	CL cases / blood donors controls	845	663	rs3731249 (Ala148Thr)	G	A	NS
Hoiom, Pigment Cell Melanoma Res, 2009	Caucasian	Sweden	CL cases / blood donors controls	845	663	CDKN2A_112Argdup	NA	NA	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	G89D	NA	NA	P
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs3731249 (Ala148Thr)	G	A	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	A57V	C	T	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs2811708 (-981G>T)	G	T	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	-735G>A	G	A	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs36228834 (-493A>T)	A	T	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs3814960 (c.-191G>A)	G	A	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	c.-33G>C	G	C	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	c.-14C>T	C	T	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	IVS1+27A>C	A	C	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs45456595 (IVS1+37G>C)	G	C	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	IVS1-122G>C (Cys41Tyr)	G	C	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	IVS2+83C>T	C	T	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs113886003 (IVS2+227A>G)	A	G	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs11515 (Nt500C>G)	C	G	NS
Goldstein, J Med Genet, 2008	Caucasian	Iceland	PO	703	691	rs3088440 (Nt540C>T)	C	T	NS
Pjanova, Melanoma Res, 2007	Caucasian	Latvian	CL cases / PO controls	125	203	rs3731249 (Ala148Thr)	G	A	P
Pjanova, Melanoma Res, 2007	Caucasian	Latvian	CL cases / PO controls	125	203	rs11515 (Nt500C>G)	C	G	NS
Pjanova, Melanoma Res, 2007	Caucasian	Latvian	CL cases / PO controls	125	203	rs3088440 (Nt540C>T)	C	T	NS
Spica, J Invest Dermatol, 2006	Caucasian	France	CL	500	143	rs3731249 (Ala148Thr)	G	A	NS
Spica, J Invest Dermatol, 2006	Caucasian	Italy	CL	119	121	rs3731249 (Ala148Thr)	G	A	NS
Debniak, Cancer Res, 2005	Caucasian	Poland	PO cases / PO - CL controls	471	1210	rs3731249 (Ala148Thr)	G	A	P
Debniak, Cancer Res, 2005	Caucasian	Poland	PO cases / PO - CL controls	471	1210	rs11515 (Nt500C>G)	C	G	NS
Debniak, Cancer Res, 2005	Caucasian	Poland	PO cases / PO - CL controls	471	1210	rs3088440 (Nt540C>T)	C	T	NS
Kumar, Int J Cancer, 2001	Caucasian	Sweden/Norway	CL cases / PO controls	229	235	rs11515 (Nt500C>G)	C	G	NS
Kumar, Int J Cancer, 2001	Caucasian	Sweden/Norway	CL cases / PO controls	229	235	rs3088440 (Nt540C>T)	C	T	P
Ibarrola-Villava, Exp Dermatol, 2010	Caucasian	Spain	CL	390	254	rs11515 (Nt500C>G)	C	G	NS
Ibarrola-Villava, Exp Dermatol, 2010	Caucasian	Spain	CL	390	254	rs3088440 (Nt540C>T)	C	T	NS
Grazzioti, J Eur Acad Dermatol Venereol, 2012	mixed	Brazil	PO	33	29	rs3088440 (Nt540C>T)	C	T	NS
Grazzioti, J Eur Acad Dermatol Venereol, 2012	mixed	Brazil	PO	33	29	rs3731249 (Ala148Thr)	G	A	NS
Grazzioti, J Eur Acad Dermatol Venereol, 2012	mixed	Brazil	PO	33	29	rs11515 (Nt500C>G)	C	G	NS
Grazzioti, J Eur Acad Dermatol Venereol, 2012	mixed	Brazil	PO	33	29	IVS2_105	A	G	NS
Stefanaki, Plos One, 2013	Caucasian	Greece	CL	284	284	rs11515 (Nt500C>G)	C	G	NS
Stefanaki, Plos One, 2013	Caucasian	Greece	CL	284	284	rs3088440 (Nt540C>T)	G	A	NS
Maccioni et al., BMC Cancer, 2013	Caucasian	Spain		837	1154	rs11515 (Nt500C>G)	G	C	ns
Maccioni et al., BMC Cancer, 2013	Caucasian	Spain		837	1154	rs3088440 (Nt540C>T)	C	T	p
Maccioni et al., BMC Cancer, 2013	Caucasian	Spain		837	1154	rs2811708	G	T	ns